AMC Settles Walking Dead Lawsuit for $120M, Cuts 2026 FCF Guidance to $150M
AMCX sits 93% above its 52-week low of $6.47.
Summary
AMC settled the Walking Dead creators' lawsuit for $120M, cutting 2026 free cash flow guidance by $70M to $150M and taking an $85M Q3 charge.
Key Events · Legal and Risk Events · AMCX
-
Walking Dead Lawsuit Settled for $120M
AMC entered a settlement agreement with Robert Kirkman and other Walking Dead producers resolving breach of contract claims. Total consideration is $120 million: $85 million cash due by September 18, 2026, and $35 million by January 31, 2027 as an advance against future participation payments.
-
2026 Free Cash Flow Guidance Cut
Free cash flow guidance for 2026 is reduced from approximately $220 million to approximately $150 million, reflecting the $85 million cash settlement payment net of related income tax benefit.
-
Q3 2026 Charge of $85 Million
The company will take a charge of approximately $85 million in the quarter ending September 30, 2026 for the settlement. Adjusted operating income is not impacted as the payment is classified as an adjustment.
-
Trial Avoided
The settlement resolves litigation originally filed in 2022, with trial previously scheduled to commence October 27, 2026. The dismissal is with prejudice.
Analysis · AMCX · Technology
AMC Global Media resolved a long-running breach of contract lawsuit with Walking Dead creators for $120 million, including an $85 million cash payment due within two weeks. The settlement forces a $70 million reduction in 2026 free cash flow guidance, from $220 million to $150 million, and triggers an $85 million charge in Q3. While the company excludes the payment from adjusted operating income, the cash outflow is real and comes just weeks after a $500 million Netflix licensing deal was announced — capital that now partially offsets this liability.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.7% of the 1838 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMCX was trading at $12.48 on NASDAQ in the Technology sector, with a market capitalization of approximately $514.8M. The 52-week trading range was $6.47 to $12.93. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.